Article

Pharma USA 2023: Changes to the Medical Affairs Function

Sunil Verma, SVP, Global Head of Oncology, Medical, AstraZeneca discusses how the Medical Affairs role will become more strategic and effective with data.

Sunil Verma, MD, SVP, Global Head of Oncology, Medical, AstraZeneca recently presented at Pharma USA 2023 on the topic, "The beginning of a new Medical, the end of an Affair." In this video, Dr. Verma tells PharmExec about how the role of medical affairs will positively influence patient outcomes and the standard of care with the use of data.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Related Videos
Related Content
Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027
August 1st 2025

Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027

Don Tracy, Associate Editor
Facing patent expiration for its blockbuster Keytruda, Merck aims to streamline operations with significant job cuts and continued R&D investments.
Jennifer Butler
August 1st 2025

The Misinformation Maze: Navigating Public Health in the Digital Age

Miranda Schmalfuhs
Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Joel Stanley
August 1st 2025

How the Entourage Effect Is Reshaping Botanical Drug Development

Joel Stanley
In many plants, the full expression of therapeutic value only emerges when their components are allowed to work in concert.
Navigating Distrust: Pharma in the Age of Social Media
August 1st 2025

Navigating Distrust: Pharma in the Age of Social Media

Miranda Schmalfuhs
Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
Credit: rudall30 | stock.adobe.com. Hands offering money with a circular chart at the center, symbolizing shareholder equity, crowdfunding, business partnerships, and investments
August 1st 2025

Capital Allocation is Strategy: Five Imperatives for Biopharma Leaders

Thani Jambulingam, PhD
Executives who treat capital allocation as a CEO-level strategic discipline are best positioned to thrive in a volatile and increasingly capital-constrained environment.
Is Community the Next Frontier for Cell and Gene Therapy?
August 1st 2025

Is Community the Next Frontier for Cell and Gene Therapy?

Elias C. Pittos, PharmD, BCOP Robert E. Richards, MS, MBA Rocky Billups, MS
Both community and academic delivery models play essential and complementary roles in expanding CGT access.